Campbell & CO Investment Adviser LLC
Position in HALO — Halozyme Therapeutics, Inc.
CIK 1353570
BALTIMORE, MD
Position in HALO
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$3,498,825
+$3,071,672 QoQ
Shares Held
44,702
+604.3% QoQ
Ownership
0.039%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#179
of 647 holders
Holding Since
Jun 2020
20 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Campbell & CO Investment Adviser LLC holds $72,173,828 across 47 Biotechnology names. HALO ranks #6 (4.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
9,899 | $6,172,422 | |
| 2 | CRSP |
CRISPR Therapeutics AG
|
107,529 | $5,864,631 | |
| 3 | CYTK |
Cytokinetics Inc
|
65,978 | $5,620,665 | |
| 4 | INSM |
INSMED Inc
|
43,856 | $4,675,926 | |
| 5 | IONS |
Ionis Pharmaceuticals Inc
|
49,632 | $3,935,321 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
This page
|
44,702 | $3,498,825 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
11,183 | $3,366,418 | |
| 8 | RPRX |
Royalty Pharma plc
|
52,688 | $2,954,216 |
All Filings in HALO
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,498,825 | 44,702 | Shares | Sole | 2026-08-03 | |
| 2025-12-31 | $427,153 | 6,347 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $4,356,616 | 59,403 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $476,139 | 9,153 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $6,509,130 | 102,008 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,860,095 | 38,906 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $1,790,352 | 31,278 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $417,047 | 7,965 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,365,139 | 33,558 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $641,958 | 17,369 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $590,763 | 15,465 | Shares | Sole | 2023-11-08 | |
| 2023-03-31 | $1,305,830 | 34,193 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $769,288 | 13,520 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $819,426 | 20,724 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $719,048 | 16,342 | Shares | Sole | 2022-08-09 | |
| 2021-09-30 | $450,124 | 11,065 | Shares | Sole | 2021-11-10 | |
| 2021-03-31 | $242,427 | 5,815 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $214,190 | 5,015 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $302,614 | 11,515 | Shares | Sole | 2020-10-15 | |
| 2020-06-30 | $399,040 | 14,884 | Shares | Sole | 2020-07-29 | |
| No filing history on record for this holder in this stock. | ||||||